Pharsight

Operand Pharms patents expiration

1. Ephedrine Sulfate patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10869845 OPERAND PHARMS Ephedrine compositions and methods
Jan, 2040

(15 years from now)

Drugs and Companies using EPHEDRINE SULFATE ingredient

Market Authorisation Date: 22 April, 2022

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

How can I launch a generic of EPHEDRINE SULFATE before it's drug patent expiration?
More Information on Dosage

EPHEDRINE SULFATE family patents

Family Patents